Cigna has been looking to sell its Medicare Advantage business, perhaps as a way to fend off antitrust objection to the deal.
Cigna and Humana are negotiations about a deal that would combine two of the largest private U.S. health insurers, the Wall Street Journal is reporting.
“The companies are discussing at stock-and-cash dela that could be finalized by the end of the year,” the newspaper reported in an article posted at 12:05 p.m.
Several media outlets have reported that Cigna has been looking to sell its Medicare Advantage (MA) business, a move that might help fend off antitrust roadblocks to the combination.
According to KFF (formerly known as the Kaiser Family Foundation), Cigna has a relatively small slice of the growing MA market with 600,000 MA enrollees that account for 2% of the Medicare beneficiaries enrolled in MA plans. Humana, with 5.5 million MA enrollees has 18% of the market and is the second largest MA insurer after UnitedHealthcare.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Cigna Reveals Multi-Year Plan to Simplify Healthcare, Boost Transparency and Improve Patient Support
February 3rd 2025This follows the company’s recent earnings call, where executives discussed the organization’s growth and future plans, highlighting its focus on serving the best interests of their consumers.
Read More
The HIV Epidemic in Trump’s America
February 3rd 2025Potential threats to HIV care and fallout over the next four years, according to Jose Abrigo, Esq., HIV project director at Lambda Legal Defense and Education Fund and Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.
Read More